Fukuda Denshi Co Ltd - Company Profile
Powered by 
All the data and insights you need on Fukuda Denshi Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Fukuda Denshi Co Ltd Strategy Report
- Understand Fukuda Denshi Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
Fukuda Denshi Co Ltd (Fukuda Denshi) develops, manufactures, and commercializes medical equipments and products including cardiology, patient monitoring, vascular screening and ultrasound systems. The company’s product portfolio includes electrocardiographs, stress tests, central and bedside monitors, central viewer workstations, transmitters, holters, defibrilattors, ultrasound systems, and cardiology and vascular screening data management systems. Fukuda Denshi offers products to health care professionals and hospitals. It has a manufacturing facility in Tokyo, Japan. The company distributes its products through direct sales force in Japan, the US, the UK, China, and Singapore, and through a network of distributors in the Americas, Europe, Africa and Asia. Fukuda Denshi is headquartered in Tokyo, Japan.
Headquarters
Japan
Address
2-35-8, Hongo, Bunkyo-Ku, Tokyo, 113-8420
Website
www.fukuda.co.jp
Telephone
81 3 56841455
No of Employees
3,382
Industry
Medical Equipment
Ticker Symbol & Exchange
6960 (TYO)
Revenue (2023)
$994.7M
1.9%
(2023 vs 2022)
EPS
XYZ
Net Income (2023)
XYZ
6.6%
(2023 vs 2022)
Market Cap*
$1.5B
Net Profit Margin (2023)
XYZ
4.5%
(2023 vs 2022)
* As of and is in US$
Fukuda Denshi Co Ltd premium industry data and analytics
Products and Services
| Products |
|---|
| Resting ECG Equipment |
| Stress ECG Examination Equipment |
| Digital Holter Recorder |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | New Products/Services | In February, the company launched the integrated TetraGraph module in Japan. |
| 2017 | Contracts/Agreements | In August, Fukuda Denshi entered into an agreement with NeuroMetrix to distribute its DPNCheck in Japan. |
| 2016 | Contracts/Agreements | In December, Fukuda Denshi entered into an agreement with Senzime AB to license and commercialize Senzime’s TetraGraph system in Japan. |
Competitor Comparison
| Key Parameters | Fukuda Denshi Co Ltd | Sysmex Corp | Nihon Kohden Corp | ConMed Corp | Menicon Co Ltd |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | United States of America | Japan |
| City | Bunkyo-Ku | Kobe-Shi | Shinjuku-Ku | Largo | Nagoya-Shi |
| State/Province | Tokyo | Hyogo | Tokyo | Florida | Aichi |
| No. of Employees | 3,382 | 9,500 | 5,751 | 4,100 | 4,056 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Kotaro Fukuda | Chief Executive Officer; Chairman | Executive Board | 2012 | 77 |
| Daijiro Shirai | President; Director | Executive Board | 2023 | 71 |
| Naoki Kuno | President; Manager Director | Senior Management | 2023 | - |
| Hiroaki Sato | Executive Officer | Senior Management | - | - |
| Kazuo Genchi | Manager Director; Chief Director of Sales | Senior Management | 2023 | 65 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer